Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Sparad:
| Institutionell upphovsman: | |
|---|---|
| Övriga upphovsmän: | |
| Materialtyp: | Elektronisk E-bok |
| Språk: | English |
| Publicerad: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Upplaga: | 1st ed. 2011. |
| Serie: | Current Topics in Microbiology and Immunology,
344 |
| Ämnen: | |
| Länkar: | https://doi.org/10.1007/978-3-642-14136-2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Lägg till första kommentaren!